Media

Media Inquiries

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]
Sort by Year
November 1, 2010

Ironwood and Forest Announce Positive Linaclotide Results from Second Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation

November 1, 2010

Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results

November 1, 2010

Almirall and Ironwood Announce Positive Results from the Second Phase 3 Trial of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation

September 13, 2010

Ironwood and Forest Announce Positive Linaclotide Results from Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation

September 13, 2010

Almirall and Ironwood Announce Positive Results from a Phase 3 Trial with Linaclotide in Patients with Irritable Bowel Syndrome with Constipation

September 13, 2010

Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results

September 9, 2010

Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference

August 5, 2010

Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update

August 2, 2010

Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call

July 28, 2010

Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010

May 26, 2010

Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call

May 11, 2010

Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update

May 7, 2010

Ironwood Pharmaceuticals Announces First Quarter 2010 Investor Update Call and Upcoming Presentation at Bank of America Merrill Lynch 2010 Health Care Conference

March 30, 2010

Ironwood Pharmaceuticals Files Annual Report on Form 10-K

February 16, 2010

Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals’ Initial Public Offering

Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.